Critical Insights From Johnson & Johnson Analyst Ratings: What You Need To Know
Portfolio Pulse from Benzinga Insights
Johnson & Johnson (NYSE:JNJ) has received diverse analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target is $190.31, slightly down from the previous $192.08. Analysts have maintained or adjusted their ratings based on market conditions, with some lowering their price targets. JNJ's financial health shows strong net margins and asset utilization, but challenges in ROE compared to industry averages.
September 03, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Johnson & Johnson has received mixed analyst ratings, with a slight decrease in the average price target. The company's financials show strong net margins but challenges in ROE.
The article provides a comprehensive overview of recent analyst ratings for JNJ, showing a slight decrease in the average price target. The financial health indicators are mixed, with strong net margins but lower ROE compared to industry averages. This suggests a neutral short-term impact on the stock price as the market digests these mixed signals.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100